Iterum Therapeutics Statistics

Total Valuation

ITRM has a market cap or net worth of $38.56 million. The enterprise value is $58.11 million.

Market Cap	38.56M
Enterprise Value	58.11M

Important Dates

The next estimated earnings date is Wednesday, August 13, 2025, before market open.

Earnings Date	Aug 13, 2025
Ex-Dividend Date	n/a

Share Statistics

ITRM has 40.00 million shares outstanding. The number of shares has increased by 78.43% in one year.

Current Share Class	40.00M
Shares Outstanding	40.00M
Shares Change (YoY)	+78.43%
Shares Change (QoQ)	+27.62%
Owned by Insiders (%)	1.03%
Owned by Institutions (%)	6.41%
Float	39.25M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.72

Current Ratio	3.72
Quick Ratio	3.49
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-6.32

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-38.60%
Return on Invested Capital (ROIC)	-46.26%
Return on Capital Employed (ROCE)	-55.35%
Revenue Per Employee	n/a
Profits Per Employee	-$2.51M
Employee Count	9
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, ITRM has paid $252,000 in taxes.

Income Tax	252,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -11.57% in the last 52 weeks. The beta is 2.79, so ITRM's price volatility has been higher than the market average.

Beta (5Y)	2.79
52-Week Price Change	-11.57%
50-Day Moving Average	1.02
200-Day Moving Average	1.34
Relative Strength Index (RSI)	44.43
Average Volume (20 Days)	532,894

Short Selling Information

The latest short interest is 1.17 million, so 2.92% of the outstanding shares have been sold short.

Short Interest	1.17M
Short Previous Month	1.08M
Short % of Shares Out	2.92%
Short % of Float	2.98%
Short Ratio (days to cover)	2.18

Income Statement

Revenue	n/a
Gross Profit	-596,000
Operating Income	-16.24M
Pretax Income	-35.05M
Net Income	-22.56M
EBITDA	-15.62M
EBIT	-16.24M
Earnings Per Share (EPS)	-$0.93

Full Income Statement

Balance Sheet

The company has $12.65 million in cash and $32.05 million in debt, giving a net cash position of -$19.39 million or -$0.48 per share.

Cash & Cash Equivalents	12.65M
Total Debt	32.05M
Net Cash	-19.39M
Net Cash Per Share	-$0.48
Equity (Book Value)	-2.55M
Book Value Per Share	-0.07
Working Capital	9.89M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$16.75 million and capital expenditures -$4,000, giving a free cash flow of -$16.75 million.

Operating Cash Flow	-16.75M
Capital Expenditures	-4,000
Free Cash Flow	-16.75M
FCF Per Share	-$0.42

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ITRM does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-78.43%
Shareholder Yield	-78.43%
Earnings Yield	-58.27%
FCF Yield	-43.26%

Analyst Forecast

The average price target for ITRM is $7.00, which is 626.22% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$7.00
Price Target Difference	626.22%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on August 18, 2022. It was a reverse split with a ratio of 0.0666667:1.

Last Split Date	Aug 18, 2022
Split Type	Reverse
Split Ratio	0.0666667:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	2